Comar, a leading supplier of conventional medical devices and special packaging assemblies and solutions, has Automatic Plastics Ltd. The company is headquartered in Wicklow, Ireland, south of Dublin. The financial terms of the transaction were not disclosed. The agreement is supported by Morgan Stanley Capital Partners. Automatic Plastics Ltd. (APL), which has been in business for 50 years and is headed by owner and director Al Lawless and sales director Andrea Cawley, specializes in custom design, development, shaping and assembly of medical devices and solid pharmaceutical packaging. APL operates in an ISO 13485-certified production plant with 30 injection molding machines weighing from 25 to 485 tons with expertise in design and development, stamping, double-injection molding, automation, handling and packaging of desiccant and custom printing.

LumiThera now says it has completed the acquisition of Diopsys for an undisclosed amount.

The acquisition of Pine Brook, a New Jersey-based manufacturer of medical devices for electrophysiology, Diopsys, was announced earlier in November. 11, 2021. Through the agreement, Diopsys shareholders will also acquire shares in LumiThera and Diopsys will become a wholly owned subsidiary of the Seattle-based company.

LumiThera will add the additional diagnostic and monitoring platform Valeda Lighting System to its platform for managing eye damage and disease. The current LumiThera platform uses photobiomodulation to treat age-related macular degeneration. Diopsys' established US sales will join LumiThera's EU sales team to serve a larger global presence of eye care professionals.

Inventya Grants has completed the merger with Cresco Innovation. The aim of this merger is to further improve their joint offering to support innovation and growth to clients through other grant writing services.

With more than a decade of experience writing grants, the Cresco team of bidders has received more than £ 30 million in grant funding for clients over the last three years.

Aldo De Leonibus, CEO of Inventya Limited, said: “We are pleased to have completed this partnership because it allows us to offer our expanded customer base enhanced services to support our mission to help new businesses succeed. products and services.United UK and international markets through finance, finance, tax relief for R&D and consulting.

Johnson & Johnson announced that DePuy Synthes, an orthopedic company of the medical giant, had bought CrossRoads Extremity Systems for an undisclosed amount.
Tennessee-based CrossRoads manufactures implants and instruments for lower limb procedures, such as certain spine and foot surgeries. In an announcement, J&J said operations for "conditions such as stabbed sticks and hammers are one of the fastest-growing features of state-of-the-art orthopaedic and podiatric procedures," as in the United States.